Loading clinical trials...
Loading clinical trials...
Clinical Endpoint Therapeutic Equivalence Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%; Mylan) to Estrace® Cream (0.01%; Warner Chilcott) in Postmenopausal Females With Atrophic Vaginitis
Conditions
Interventions
Estradiol Vaginal Cream, 0.01%
Estrace® 0.01% cream
+1 more
Locations
21
United States
ARA-Arizona Research Associates
Tucson, Arizona, United States
Axis Clinical Trials
Los Angeles, California, United States
Northern CA Research
Sacramento, California, United States
MCCR
San Diego, California, United States
Women's Health Care Research Corp.
San Diego, California, United States
MCB Clinical Research Centers
Colorado Springs, Colorado, United States
Start Date
June 1, 2014
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
March 9, 2022
NCT04045379
NCT00984399
NCT04219605
NCT06808347
NCT01370551
NCT02460302
Lead Sponsor
Mylan Pharmaceuticals Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions